Treatment of cancer pain with neurolytic agents.
D014150:Antipsychotic Agents / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology*; D009407:Nerve Block; D009474:Neurons / Q000187:drug effects; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D013346:Subarachnoid Space
D014150:Antipsychotic Agents